home / stock / fujiy / fujiy news


FUJIY News and Press, FUJIFILM Holdings Corp ADR 2 Ord From 02/07/23

Stock Information

Company Name: FUJIFILM Holdings Corp ADR 2 Ord
Stock Symbol: FUJIY
Market: OTC

Menu

FUJIY FUJIY Quote FUJIY Short FUJIY News FUJIY Articles FUJIY Message Board
Get FUJIY Alerts

News, Short Squeeze, Breakout and More Instantly...

FUJIY - Xerox's 5.9% Dividend Yield Makes It A Buy For Income-Seeking Investors

Summary Xerox currently has a very attractive dividend yield of 5.9%. A new FITTLE financing deal announced in early January should significantly improve Xerox's cash flow. Carl Icahn controls 22% of Xerox. The results last year were hurt by sharply rising costs and supply chain...

FUJIY - FUJIFILM Holdings (FUJIY) Presents At 41st Annual J.P. Morgan Healthcare Conference

The following slide deck was published by FUJIFILM Holdings Corporation in conjunction with this event. For further details see: FUJIFILM Holdings (FUJIY) Presents At 41st Annual J.P. Morgan Healthcare Conference

FUJIY - GE HealthCare: Great Company, For Watchlist

Summary GEHC is the best performing unit of GE, and now you can buy the company on its own. With a moat across multiple industries, profitability, and innovation, I believe the fundamentals of the company are rock solid. The issue is predicting where the valuation will find equilibr...

FUJIY - Carl Zeiss Meditec: Buying Opportunity For A Stable Compounding Business

Summary Carl Zeiss Meditec recorded strong order growth of 36% YoY in Q3 FY9/2022 results, highlighting strong underlying demand. Operating margins look stable at 20%, driven by an improving sales mix despite ongoing investment in R&D and marketing activities. The shares h...

FUJIY - Argenx inks manufacturing contract for efgartigimod with Fujifilm Diosynth

Fujifilm Diosynth Biotechnologies on Thursday said it signed an agreement to manufacture argenx's ( NASDAQ: ARGX ) ( OTC:ARGNF ) monoclonal antibody efgartigimod to treat severe autoimmune disease. Fujifilm Diosynth, a unit of Japan's Fujifilm H...

FUJIY - Fujifilm to discontinue development of influenza drug Avigan as COVID-19 therapy

Japan's Fujifilm Holdings ( OTCPK:FUJIY ) ( OTCPK:FUJIF ) said it is discontinuing the development of its anti-influenza oral drug Avigan (favipiravir) for use against COVID-19, after trial data did not show significant results. In 2021, Fujifilm Toyama Chemi...

FUJIY - Dear NVAX Stock Fans, Mark Your Calendars for Oct. 11

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Shares of Novavax (NASDAQ: NVAX ) are in focus, as the biotechnology company will share data from its Covid-19-Influenza Combination (CIC) vaccine candidate for Phase 1 and 2 trials at the World Vaccine Congress (WV...

FUJIY - Novavax to pay FUJIFILM up to $185M after cancelling manufacturing contract

Novavax ( NASDAQ: NVAX ) will pay FUJIFILM Holdings ( OTCPK:FUJIF ) up to $185M as a result of ending manufacturing as part of a commercial supply agreement. Novavax will pay $34.3M in four equal quarterly installments beginning on March 31, 2023, according to an SEC...

FUJIY - FUJIFILM to invest $350M in US electronic materials business

FUJIFILM Electronic Materials ( OTCPK:FUJIY ) announced strategic investment of $350M in its U.S. business during its fiscal year period FY21 – FY23 (April 1, 2021 – March 31, 2024). This $350M represents ~35% of Fujifilm’s planned global investm...

FUJIY - Fujifilm to invest $1.6B to enhance and expand icell culture manufacturing services

FUJIFILM Corporation ( OTCPK:FUJIY ) announced the investment of $1.6B to enhance and expand the cell culture manufacturing services of it's subsidiary FUJIFILM Diosynth Biotechnologies’ sites in Hillerød, Denmark, and Texas in the United States. FUJIFILM Diosynth ...

Previous 10 Next 10